PPIs May Decrease the Effectiveness of Hepatitis C Antivirals

Pharmacy Today
doi 10.1016/j.ptdy.2018.04.010
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Editorial: Direct-Acting Antivirals Decrease the Frequency of Diabetes Complications in Patients With Chronic Hepatitis C

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Systematic Review: Cost-Effectiveness of Direct-Acting Antivirals for Treatment of Hepatitis C Genotypes 2-6

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Plant-Derived Antivirals Against Hepatitis C Virus Infection

Virology Journal
VirologyInfectious Diseases
2018English

Hepatitis C Related Hepatocellular Carcinoma in the Era of Direct-Acting Antivirals

Hepatoma Research
2018English

Treating Hepatitis B Virus/Hepatitis C Virus Coinfected Patients With Direct-Acting Hepatitis C Virus Antivirals Only Is Not Safe

Hepatology
MedicineHepatology
2016English

Evaluation of Hepatitis B Reactivation Among 62,920 Veterans Treated With Oral Hepatitis C Antivirals

Hepatology
MedicineHepatology
2017English

Challenges and Perspectives of Direct Antivirals for the Treatment of Hepatitis C Virus Infection

Journal of Hepatology
Hepatology
2018English

Efficiency of Immunocorrection in Сhronic Viral Hepatitis C Patients Treated by Antivirals

Russian Journal of Infection and Immunity
Infectious DiseasesAllergyImmunology
2014English

The Interplay Between Direct-Acting Antivirals and Hepatocellular Carcinoma in Chronic Hepatitis C

Hepatoma Research
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy